Standard BioTools Inc. (LAB)
NASDAQ: LAB · IEX Real-Time Price · USD
1.770
+0.040 (2.31%)
At close: Jul 2, 2024, 4:00 PM
1.760
-0.010 (-0.56%)
After-hours: Jul 2, 2024, 7:18 PM EDT
Standard BioTools Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Standard BioTools stock have an average target of 3.58, with a low estimate of 3.25 and a high estimate of 4.00. The average target predicts an increase of 102.26% from the current stock price of 1.77.
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 16, 2024.
Analyst Ratings
The average analyst rating for LAB stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|
| Strong Buy | 0 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +97.74% | Apr 16, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $3.25 | Strong Buy | Initiates | $3.25 | +83.62% | Apr 4, 2024 |
| Keybanc | Keybanc | Buy Initiates $4 | Buy | Initiates | $4 | +125.99% | Jul 12, 2023 |
Financial Forecast
Revenue This Year
203.19M
from 106.34M
Increased by 91.08%
Revenue Next Year
234.73M
from 203.19M
Increased by 15.52%
EPS This Year
0.06
from -0.94
EPS Next Year
-0.21
from 0.06
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 213.1M | 247.0M | 315.0M | 326.9M |
| Avg | 203.2M | 234.7M | 280.5M | 314.4M |
| Low | 196.0M | 222.5M | 255.1M | 305.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 100.3% | 21.5% | 34.2% | 16.5% |
| Avg | 91.1% | 15.5% | 19.5% | 12.1% |
| Low | 84.3% | 9.5% | 8.7% | 8.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 0.46 | -0.18 | 0.02 | -0.02 |
| Avg | 0.06 | -0.21 | -0.05 | -0.02 |
| Low | -0.32 | -0.24 | -0.12 | -0.02 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.